SCHEMBL6973700

SCHEMBL6973700

COc1ccc2c(c1)c(OCc1ccc(F)cc1)nn2S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 2/20 0.45
CNR2 P34972 3/20 0.44
ACHE P22303 2/20 0.44
CNR1 P21554 2/20 0.43
MAOB P27338 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
KDM4E B2RXH2 2/20 0.42
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
PTGDR Q13258 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977071 0.87 HTR6 (0.44) HTR6CYP3A4CYP2D6TP53
SCHEMBL6977129 0.87 PPARG (0.43) HTR6CYP3A4CYP2D6MAOB
SCHEMBL6977903 0.85 AR (0.46) HTR6CNR2ACHECNR1MAOB
SCHEMBL6966090 0.84 HTR6 (0.44) HTR6CYP3A4CYP2D6CA12CA1
SCHEMBL6961975 0.81 PTGDR (0.42) HTR6CYP3A4CYP2D6PTGDRPTGDR2
SCHEMBL6965738 0.80 MAPT (0.44) HTR6KDM4EALDH1A1TP53
SCHEMBL6977906 0.79 CNR2 (0.40) HTR6CNR2ACHECNR1MAOB
SCHEMBL6967275 0.79 HTR6 (0.42) HTR6CYP3A4CYP2D6KDM4EPTGDR
SCHEMBL6966615 0.79 KMT2A (0.43) HTR6CYP3A4CYP2D6KDM4EPTGDR
SCHEMBL6971624 0.78 HTR6 (0.41) HTR6CYP3A4CYP2D6KDM4EPTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077947-B1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS DRESDEN ARZNEIMITTEL (DE) 2003-09-03 EP claimed